» Authors » Peter Simos

Peter Simos

Explore the profile of Peter Simos including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 5
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart A, Simos P, Sivabalan P, Escola-Verge L, Garnham K, Isler B
Antibiotics (Basel) . 2024 Nov; 13(11). PMID: 39596730
Bloodstream infections (BSIs) remain a significant source of morbidity and mortality globally, exacerbated by an ageing population and rising antimicrobial resistance (AMR). This review offers an updated evaluation of randomized...
2.
Badrick T, Meumann E, Shirley K, Simos P, May M, Quagliotto G, et al.
Med J Aust . 2024 May; 220(10):505-506. PMID: 38741384
No abstract available.
3.
Grey V, Simos P, Runnegar N, Eisemann J
Access Microbiol . 2023 Dec; 5(11). PMID: 38074103
Diagnosis of chronic Q fever is often difficult for clinicians, particularly in the presence of a second pathology. In addition to the chronic constitutional symptoms, the most common manifestations of...
4.
Simos P, Scott I
Postgrad Med J . 2023 May; 99(1170):279-285. PMID: 37227975
Study Purpose: Routine transthoracic echocardiography (TTE) in patients with syncope or presyncope is resource-intensive. We assessed if risk thresholds defined by a validated risk score may identify patients at low...
5.
Gramp P, Dooley J, OBrien B, Jones A, Tan L, Robson J, et al.
Australas J Dermatol . 2023 May; 64(3):e256-e261. PMID: 37154242
We present a case of a 66-year-old man with a cutaneous Balamuthia mandrillaris lesion that progressed to fatal granulomatous amoebic encephalitis. We provide a summary of Australian cases and describe...
6.
Simos P, Scott I
Postgrad Med J . 2023 Apr; PMID: 37073600
Study Purpose: Routine transthoracic echocardiography (TTE) in patients with syncope or presyncope is resource-intensive. We assessed if risk thresholds defined by a validated risk score may identify patients at low...
7.
Stewart A, Isler B, Simos P, Farquhar D, George N, Golmayo M, et al.
Mycopathologia . 2023 Apr; 188(3):211-219. PMID: 37067664
Background: Aspergillus species are important causes of invasive fungal disease, particularly among those with an impaired immune system. Increasing reports have revealed a rising incidence of antifungal drug resistance among...
8.
Isler B, Vatansever C, Ozer B, Cinar G, Aslan A, Stewart A, et al.
Diagn Microbiol Infect Dis . 2022 Jul; 104(1):115745. PMID: 35843111
Ceftazidime-avibactam exhibits good in vitro activity against carbapenem resistant Klebsiella carrying OXA-48-like enzymes. We tested two hundred unique carbapenem resistant Klebsiella blood stream isolates (71% with single OXA-48-like carbapenemases, including...
9.
Simos P, Stewart A
Intern Med J . 2022 Feb; 52(2):332-333. PMID: 35187825
No abstract available.